
Vali oma silt
näidatakse otse viaalil8 laboriaruannet
PDF- Testitud
- Tirzepatide 10mg
- Labor
- Analiza Białek
- Kuupäev
- November 2026
- Tulemus
- 99% purity (10.88 mg measured)
- Endotoksiinid
- 5.99 EU/vial
- Tellimuse nr
- Parool
PDF- Testitud
- Tirzepatide 15mg
- Labor
- Analiza Białek
- Kuupäev
- November 2026
- Tulemus
- 99% purity (15.41 mg measured)
- Endotoksiinid
- 6.37 EU/vial
- Tellimuse nr
- Parool
PDF- Testitud
- Tirzepatide 40mg
- Labor
- Analiza Białek
- Kuupäev
- November 2026
- Tulemus
- 99% purity (40.34 mg measured)
- Endotoksiinid
- 7.44 EU/vial
- Tellimuse nr
- Parool
PDF- Testitud
- Tirzepatide 50mg
- Labor
- Analiza Białek
- Kuupäev
- November 2026
- Tulemus
- 99% purity (54.79 mg measured)
- Endotoksiinid
- 8.23 EU/vial
- Tellimuse nr
- Parool
PDF- Testitud
- Tirzepatide 100mg
- Labor
- Analiza Białek
- Kuupäev
- November 2026
- Tulemus
- 99% purity (108.24 mg measured)
- Endotoksiinid
- 9.87 EU/vial
- Tellimuse nr
- Parool
PDF- Testitud
- Tirzepatide 20mg
- Labor
- Analiza Białek
- Kuupäev
- October 2026
- Tulemus
- 99% purity (21.80 mg measured)
- Endotoksiinid
- 6.21 EU/vial
- Tellimuse nr
- Parool
PDF- Testitud
- Tirzepatide 60mg
- Labor
- Analiza Białek
- Kuupäev
- September 2026
- Tulemus
- 99% purity (64.85 mg measured), microbial test passed
- Endotoksiinid
- 5.96 EU/vial
- Tellimuse nr
- Parool
PDF- Testitud
- Tirzepatide 5mg
- Labor
- Analiza Białek
- Kuupäev
- July 2026
- Tulemus
- 99% purity (5.48 mg measured)
- Tellimuse nr
- Parool
Sõltumatult testitud, kontrollitav parooliga otse laboris.
Tirzepatide
GLP-1
- Laboris testitud · 99% puhtus
- Saadetakse Saksamaalt
Tellimus
- DHL koos jälgimisega
- Diskreetne pakend
4.6 5-st Trustpilotis73 arvustust
Otsitud ka nimega: Tirzepatid · Tirze · LY3298176
Lühidalt
Tirzepatide arvudes
Põhinäitajad meie leksikonist. Lohista punkti mööda kõverat, et näha, kui palju jääb pärast ühte annust arvutuslikult alles.
Täielik leksikoni artikkelHow long does it stay in the body?
Share left after one dose, calculated with a half-life of ~5 days
Simplified model without an absorption phase, half-life from the TPD lexicon.
Half-life
~5days
- Class
- Dual GIP / GLP-1 agonist
- Frequency
- Once weeklysubcutaneous
- Form
- Lyophilised powderreconstituted with BAC water
- Sizes
- 5 to 120 mg10 sizes in the shop
What studies show
All 4 sources in the lexicon- Frias et al., The Lancet, 2018
SURMOUNT-1 - once-weekly tirzepatide for weight research (opens in a new tab)
Jastreboff et al., New England Journal of Medicine, 2022Review of the dual GIP/GLP-1 mechanism (opens in a new tab)
Gallwitz, Frontiers in Endocrinology, 2022
Teadmised
Kõik teemal Tirzepatide
Üksikasjalik teave tuleb peagi.
Annustamine
Annustamisteabe laadimine …
Telli kohe kaasa
Mida sul sellega vaja on
Bakteriostaatiline vesi lisatakse ostukorvi automaatselt. Süstlad ja lapid ühe klõpsuga.
Insuliinisüstlad
10 tk · 5.50 €
Alkoholilapid
50 tk · 10 €
Kui palju vett?
Ühikud süstlal sinu viaali suuruse jaoks.
Ava kalkulaator →Is Tirzepatide approved?
Yes. The first approval came in May 2022 in the USA for type 2 diabetes, the European Medicines Agency issued a positive opinion shortly after. ChEMBL now lists type 2 diabetes, obesity and overweight as approved indications. The information here describes the state of research and is not a recommendation for use.
How does Tirzepatide differ from Semaglutide and Retatrutide?
The number of receptors. Semaglutide acts only on the GLP-1 receptor, Tirzepatide on GIP and GLP-1, Retatrutide also on the glucagon receptor. In a head-to-head trial against semaglutide (SURMOUNT-5) weight fell by 20.2 versus 13.7 percent after 72 weeks. A comparison with Retatrutide is still running (TRIUMPH-5, planned end November 2026).
What did the phase 3 trials show?
In SURMOUNT-1 (obesity without diabetes) weight fell by 20.9 percent on average after 72 weeks at the highest study dose, by 3.1 percent on placebo. In SURMOUNT-2 (with type 2 diabetes) it was 14.7 versus 3.2 percent. In SURPASS-1 long-term blood sugar (HbA1c) fell by up to 2.07 percentage points in 40 weeks, on placebo it rose slightly.
How long does Tirzepatide stay in the body?
The half-life in the first human study was about five days (116.7 hours on average). A fatty acid attached to the molecule makes this possible: it lets the molecule bind to the blood protein albumin. That fits one dose a week, which is how the trials give it.
What happens after stopping?
SURMOUNT-4 tested this. After 36 weeks of Tirzepatide everyone had lost 20.9 percent on average. Those switched to placebo regained 14.0 percent on average by week 88. Those who continued lost a further 5.5 percent. Over the whole period it was 25.3 versus 9.9 percent.
Which side effects were seen?
Most often gastrointestinal effects such as nausea, diarrhoea and vomiting, mostly mild to moderate and mainly while the dose was being increased. In SURMOUNT-1 4.3 to 7.1 percent stopped because of side effects depending on the dose, 2.6 percent on placebo. A phase 2 trial showed that a lower start and smaller steps went along with fewer complaints.
What is known about heart, liver and sleep apnoea?
In SUMMIT (heart failure with preserved ejection fraction and obesity) 9.9 percent had cardiovascular death or worsening heart failure, 15.3 percent on placebo. In SURPASS-CVOT Tirzepatide was not worse than dulaglutide for cardiovascular events. In SYNERGY-NASH MASH resolved in 62 percent at the highest study dose, in 10 percent on placebo. In sleep apnoea the number of breathing pauses per hour fell by 25.3 in one of the two trials, by 5.3 on placebo.
Which trials are still running?
Six of the listed phase 3 trials are not finished yet. The largest is SURMOUNT-MMO on morbidity and mortality in obesity with 15,374 participants (planned end October 2027). There are also trials in type 1 diabetes, in adolescents and in children aged 6 to 11.
Võrdlused
Kuidas see võrdub
Seotud
Seotud tooted
Retatrutide
Peptiidid · GLP-1 ja rasvapõletus GLP-1 ja rasvapõletus
11 suurust
Laboris testitud
= alates 16 €/viaal
Semaglutide
Peptiidid · GLP-1 ja rasvapõletus GLP-1 ja rasvapõletus
6 suurust
Laboris testitud
= alates 10 €/viaal
Mazdutide
Peptiidid · GLP-1 ja rasvapõletus GLP-1 ja rasvapõletus
2 suurust
= alates 32 €/viaal
Survodutide
Peptiidid · GLP-1 ja rasvapõletus GLP-1 ja rasvapõletus
1 suurus
= 60.8 €/viaal
Tirzepatide

